Greenville, S.C. (PRWEB) November 23, 2013
The Greenville Health System’s Human Performance Laboratory – expected to open in January 2014 – is the first HPL in the nation to be fully embedded into a cancer research and treatment program.
The HPL, which already is working with a limited number of patients on a pilot basis, is a collaborative effort between GHS and the University Of South Carolina School Of Medicine Greenville. While its initial focus is on cancer survivor patients in the GHS Cancer Institute, the lab will ultimately serve all GHS clinical populations.
Human performance labs traditionally have been the province of elite athletes who use the state-of-the-art analysis to improve performance. This the first time that a HPL will be used by a cancer institute to measure the changes in post-treatment cancer survivors -- from whole body function all the way down the cellular level -- in an effort to improve patient health and outcomes. The 1,000-square-foot lab, based at the GHS Cancer Institute, will measure cardiorespiratory fitness, muscular strength, body composition and metabolic fitness down to the mitochondrial level.
“By determining how exercise affects survivor’s health and outcomes, we can develop new cancer management techniques that will help patients overcome the crippling fatigue that too often accompanies cancer treatment,” said the institute’s medical director, Larry Gluck, MD.
“If achieved, this patient-recovery milestone would be on par with how chemotherapy-induced nausea was significantly reduced by harnessing better-targeted medications, said Gluck. “It’s not enough to survive. You have to feel like you’re actually living a life,” he said.
As many as 200-300 patients could take part in the Human Performance Lab in its first year.
Gluck is a leader in the national cancer-rehab movement. He started the GHS “Moving On” oncology rehabilitation program in
Copyright©2012 Vocus, Inc.
All rights reserved